Loading…
Kinetics of TCR Use in Response to Repeated Epitope-Specific Immunization
Selection of T cell-directed immunization strategies is based extensively on discordant information derived from preclinical models. We characterized the kinetics of T cell selection in response to repeated antigenic challenge. By enumerating with epitope/HLA tetrameric complexes (tHLA) vaccine-elic...
Saved in:
Published in: | The Journal of immunology (1950) 2001-05, Vol.166 (9), p.5817-5825 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c409t-d520c629bece3555584c8bbe554335cad07a6ac645618c361515591d9e0ec3773 |
---|---|
cites | cdi_FETCH-LOGICAL-c409t-d520c629bece3555584c8bbe554335cad07a6ac645618c361515591d9e0ec3773 |
container_end_page | 5825 |
container_issue | 9 |
container_start_page | 5817 |
container_title | The Journal of immunology (1950) |
container_volume | 166 |
creator | Monsurro, Vladia Nielsen, Mai-Britt Perez-Diez, Ainhoa Dudley, Mark E Wang, Ena Rosenberg, Steven A Marincola, Francesco M |
description | Selection of T cell-directed immunization strategies is based extensively on discordant information derived from preclinical models. We characterized the kinetics of T cell selection in response to repeated antigenic challenge. By enumerating with epitope/HLA tetrameric complexes (tHLA) vaccine-elicited T cell precursor frequencies (Tc-pf) in melanoma patients exposed to the modified gp100 epitope gp100:209-217 (g209-2M) we observed in most patients that the Tc-pf increased with number of immunizations. One patient's kinetics were further characterized. Dissociation kinetics of g209-2M/tHLA suggested enrichment of T cell effector populations expressing TCR with progressively higher affinity. Furthermore, vaccine-elicited T cells maintained the ability to express IFN-gamma ex vivo and proliferate in vitro. Thus, repeated exposure to immunogenic peptides benefited immune competence. These results provide a rationale for immunization strategies. |
doi_str_mv | 10.4049/jimmunol.166.9.5817 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77073569</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77073569</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-d520c629bece3555584c8bbe554335cad07a6ac645618c361515591d9e0ec3773</originalsourceid><addsrcrecordid>eNqFkE1Lw0AQhhdRbK3-AkFy0lPqbvYrOUqpWiwItT0vm83EbkmyMZtS9Ne7pRW9OZeZwzMvMw9C1wSPGWbZ_cbW9bZx1ZgIMc7GPCXyBA0J5zgWAotTNMQ4SWIihRygC-83GGOBE3aOBoRQQlkihmj2YhvorfGRK6PlZBGtPES2iRbgW9eEuXdhbkH3UETT1vauhfitBWNLa6LZ_gL7pXvrmkt0VurKw9Wxj9DqcbqcPMfz16fZ5GEeG4azPi54go1IshwMUB4qZSbNc-CcUcqNLrDUQhvBuCCpoYLw8FFGigwwGColHaHbQ27buY8t-F7V1huoKt2A23olJZaUi-xfkMiUJSyIGCF6AE3nvO-gVG1na919KoLVXrX6Ua2CapWpveqwdXOM3-Y1FL87R7cBuDsAa_u-3tkOlK91VQWcqN1u9yfqG-tXiKU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17842431</pqid></control><display><type>article</type><title>Kinetics of TCR Use in Response to Repeated Epitope-Specific Immunization</title><source>Free E-Journal (出版社公開部分のみ)</source><creator>Monsurro, Vladia ; Nielsen, Mai-Britt ; Perez-Diez, Ainhoa ; Dudley, Mark E ; Wang, Ena ; Rosenberg, Steven A ; Marincola, Francesco M</creator><creatorcontrib>Monsurro, Vladia ; Nielsen, Mai-Britt ; Perez-Diez, Ainhoa ; Dudley, Mark E ; Wang, Ena ; Rosenberg, Steven A ; Marincola, Francesco M</creatorcontrib><description>Selection of T cell-directed immunization strategies is based extensively on discordant information derived from preclinical models. We characterized the kinetics of T cell selection in response to repeated antigenic challenge. By enumerating with epitope/HLA tetrameric complexes (tHLA) vaccine-elicited T cell precursor frequencies (Tc-pf) in melanoma patients exposed to the modified gp100 epitope gp100:209-217 (g209-2M) we observed in most patients that the Tc-pf increased with number of immunizations. One patient's kinetics were further characterized. Dissociation kinetics of g209-2M/tHLA suggested enrichment of T cell effector populations expressing TCR with progressively higher affinity. Furthermore, vaccine-elicited T cells maintained the ability to express IFN-gamma ex vivo and proliferate in vitro. Thus, repeated exposure to immunogenic peptides benefited immune competence. These results provide a rationale for immunization strategies.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.166.9.5817</identifier><identifier>PMID: 11313426</identifier><language>eng</language><publisher>United States: Am Assoc Immnol</publisher><subject>Cancer Vaccines - administration & dosage ; Cancer Vaccines - immunology ; Clone Cells ; Dose-Response Relationship, Immunologic ; Down-Regulation - immunology ; Epitopes, T-Lymphocyte - immunology ; Epitopes, T-Lymphocyte - metabolism ; gp100 Melanoma Antigen ; HLA Antigens - analysis ; Humans ; Immunization Schedule ; Kinetics ; Ligands ; Lymphocyte Activation ; Lymphocyte Count ; Melanoma - immunology ; Membrane Glycoproteins - administration & dosage ; Membrane Glycoproteins - immunology ; Neoplasm Proteins - administration & dosage ; Neoplasm Proteins - immunology ; Peptide Fragments - administration & dosage ; Peptide Fragments - immunology ; Peptides ; Protein Binding - immunology ; Receptors, Antigen, T-Cell - metabolism ; Stem Cells - immunology ; Stem Cells - metabolism ; Stem Cells - pathology ; T-Lymphocytes - immunology ; T-Lymphocytes - metabolism ; T-Lymphocytes - pathology ; Tumor Cells, Cultured</subject><ispartof>The Journal of immunology (1950), 2001-05, Vol.166 (9), p.5817-5825</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-d520c629bece3555584c8bbe554335cad07a6ac645618c361515591d9e0ec3773</citedby><cites>FETCH-LOGICAL-c409t-d520c629bece3555584c8bbe554335cad07a6ac645618c361515591d9e0ec3773</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11313426$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Monsurro, Vladia</creatorcontrib><creatorcontrib>Nielsen, Mai-Britt</creatorcontrib><creatorcontrib>Perez-Diez, Ainhoa</creatorcontrib><creatorcontrib>Dudley, Mark E</creatorcontrib><creatorcontrib>Wang, Ena</creatorcontrib><creatorcontrib>Rosenberg, Steven A</creatorcontrib><creatorcontrib>Marincola, Francesco M</creatorcontrib><title>Kinetics of TCR Use in Response to Repeated Epitope-Specific Immunization</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>Selection of T cell-directed immunization strategies is based extensively on discordant information derived from preclinical models. We characterized the kinetics of T cell selection in response to repeated antigenic challenge. By enumerating with epitope/HLA tetrameric complexes (tHLA) vaccine-elicited T cell precursor frequencies (Tc-pf) in melanoma patients exposed to the modified gp100 epitope gp100:209-217 (g209-2M) we observed in most patients that the Tc-pf increased with number of immunizations. One patient's kinetics were further characterized. Dissociation kinetics of g209-2M/tHLA suggested enrichment of T cell effector populations expressing TCR with progressively higher affinity. Furthermore, vaccine-elicited T cells maintained the ability to express IFN-gamma ex vivo and proliferate in vitro. Thus, repeated exposure to immunogenic peptides benefited immune competence. These results provide a rationale for immunization strategies.</description><subject>Cancer Vaccines - administration & dosage</subject><subject>Cancer Vaccines - immunology</subject><subject>Clone Cells</subject><subject>Dose-Response Relationship, Immunologic</subject><subject>Down-Regulation - immunology</subject><subject>Epitopes, T-Lymphocyte - immunology</subject><subject>Epitopes, T-Lymphocyte - metabolism</subject><subject>gp100 Melanoma Antigen</subject><subject>HLA Antigens - analysis</subject><subject>Humans</subject><subject>Immunization Schedule</subject><subject>Kinetics</subject><subject>Ligands</subject><subject>Lymphocyte Activation</subject><subject>Lymphocyte Count</subject><subject>Melanoma - immunology</subject><subject>Membrane Glycoproteins - administration & dosage</subject><subject>Membrane Glycoproteins - immunology</subject><subject>Neoplasm Proteins - administration & dosage</subject><subject>Neoplasm Proteins - immunology</subject><subject>Peptide Fragments - administration & dosage</subject><subject>Peptide Fragments - immunology</subject><subject>Peptides</subject><subject>Protein Binding - immunology</subject><subject>Receptors, Antigen, T-Cell - metabolism</subject><subject>Stem Cells - immunology</subject><subject>Stem Cells - metabolism</subject><subject>Stem Cells - pathology</subject><subject>T-Lymphocytes - immunology</subject><subject>T-Lymphocytes - metabolism</subject><subject>T-Lymphocytes - pathology</subject><subject>Tumor Cells, Cultured</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqFkE1Lw0AQhhdRbK3-AkFy0lPqbvYrOUqpWiwItT0vm83EbkmyMZtS9Ne7pRW9OZeZwzMvMw9C1wSPGWbZ_cbW9bZx1ZgIMc7GPCXyBA0J5zgWAotTNMQ4SWIihRygC-83GGOBE3aOBoRQQlkihmj2YhvorfGRK6PlZBGtPES2iRbgW9eEuXdhbkH3UETT1vauhfitBWNLa6LZ_gL7pXvrmkt0VurKw9Wxj9DqcbqcPMfz16fZ5GEeG4azPi54go1IshwMUB4qZSbNc-CcUcqNLrDUQhvBuCCpoYLw8FFGigwwGColHaHbQ27buY8t-F7V1huoKt2A23olJZaUi-xfkMiUJSyIGCF6AE3nvO-gVG1na919KoLVXrX6Ua2CapWpveqwdXOM3-Y1FL87R7cBuDsAa_u-3tkOlK91VQWcqN1u9yfqG-tXiKU</recordid><startdate>20010501</startdate><enddate>20010501</enddate><creator>Monsurro, Vladia</creator><creator>Nielsen, Mai-Britt</creator><creator>Perez-Diez, Ainhoa</creator><creator>Dudley, Mark E</creator><creator>Wang, Ena</creator><creator>Rosenberg, Steven A</creator><creator>Marincola, Francesco M</creator><general>Am Assoc Immnol</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20010501</creationdate><title>Kinetics of TCR Use in Response to Repeated Epitope-Specific Immunization</title><author>Monsurro, Vladia ; Nielsen, Mai-Britt ; Perez-Diez, Ainhoa ; Dudley, Mark E ; Wang, Ena ; Rosenberg, Steven A ; Marincola, Francesco M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-d520c629bece3555584c8bbe554335cad07a6ac645618c361515591d9e0ec3773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Cancer Vaccines - administration & dosage</topic><topic>Cancer Vaccines - immunology</topic><topic>Clone Cells</topic><topic>Dose-Response Relationship, Immunologic</topic><topic>Down-Regulation - immunology</topic><topic>Epitopes, T-Lymphocyte - immunology</topic><topic>Epitopes, T-Lymphocyte - metabolism</topic><topic>gp100 Melanoma Antigen</topic><topic>HLA Antigens - analysis</topic><topic>Humans</topic><topic>Immunization Schedule</topic><topic>Kinetics</topic><topic>Ligands</topic><topic>Lymphocyte Activation</topic><topic>Lymphocyte Count</topic><topic>Melanoma - immunology</topic><topic>Membrane Glycoproteins - administration & dosage</topic><topic>Membrane Glycoproteins - immunology</topic><topic>Neoplasm Proteins - administration & dosage</topic><topic>Neoplasm Proteins - immunology</topic><topic>Peptide Fragments - administration & dosage</topic><topic>Peptide Fragments - immunology</topic><topic>Peptides</topic><topic>Protein Binding - immunology</topic><topic>Receptors, Antigen, T-Cell - metabolism</topic><topic>Stem Cells - immunology</topic><topic>Stem Cells - metabolism</topic><topic>Stem Cells - pathology</topic><topic>T-Lymphocytes - immunology</topic><topic>T-Lymphocytes - metabolism</topic><topic>T-Lymphocytes - pathology</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Monsurro, Vladia</creatorcontrib><creatorcontrib>Nielsen, Mai-Britt</creatorcontrib><creatorcontrib>Perez-Diez, Ainhoa</creatorcontrib><creatorcontrib>Dudley, Mark E</creatorcontrib><creatorcontrib>Wang, Ena</creatorcontrib><creatorcontrib>Rosenberg, Steven A</creatorcontrib><creatorcontrib>Marincola, Francesco M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Monsurro, Vladia</au><au>Nielsen, Mai-Britt</au><au>Perez-Diez, Ainhoa</au><au>Dudley, Mark E</au><au>Wang, Ena</au><au>Rosenberg, Steven A</au><au>Marincola, Francesco M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kinetics of TCR Use in Response to Repeated Epitope-Specific Immunization</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>2001-05-01</date><risdate>2001</risdate><volume>166</volume><issue>9</issue><spage>5817</spage><epage>5825</epage><pages>5817-5825</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>Selection of T cell-directed immunization strategies is based extensively on discordant information derived from preclinical models. We characterized the kinetics of T cell selection in response to repeated antigenic challenge. By enumerating with epitope/HLA tetrameric complexes (tHLA) vaccine-elicited T cell precursor frequencies (Tc-pf) in melanoma patients exposed to the modified gp100 epitope gp100:209-217 (g209-2M) we observed in most patients that the Tc-pf increased with number of immunizations. One patient's kinetics were further characterized. Dissociation kinetics of g209-2M/tHLA suggested enrichment of T cell effector populations expressing TCR with progressively higher affinity. Furthermore, vaccine-elicited T cells maintained the ability to express IFN-gamma ex vivo and proliferate in vitro. Thus, repeated exposure to immunogenic peptides benefited immune competence. These results provide a rationale for immunization strategies.</abstract><cop>United States</cop><pub>Am Assoc Immnol</pub><pmid>11313426</pmid><doi>10.4049/jimmunol.166.9.5817</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1767 |
ispartof | The Journal of immunology (1950), 2001-05, Vol.166 (9), p.5817-5825 |
issn | 0022-1767 1550-6606 |
language | eng |
recordid | cdi_proquest_miscellaneous_77073569 |
source | Free E-Journal (出版社公開部分のみ) |
subjects | Cancer Vaccines - administration & dosage Cancer Vaccines - immunology Clone Cells Dose-Response Relationship, Immunologic Down-Regulation - immunology Epitopes, T-Lymphocyte - immunology Epitopes, T-Lymphocyte - metabolism gp100 Melanoma Antigen HLA Antigens - analysis Humans Immunization Schedule Kinetics Ligands Lymphocyte Activation Lymphocyte Count Melanoma - immunology Membrane Glycoproteins - administration & dosage Membrane Glycoproteins - immunology Neoplasm Proteins - administration & dosage Neoplasm Proteins - immunology Peptide Fragments - administration & dosage Peptide Fragments - immunology Peptides Protein Binding - immunology Receptors, Antigen, T-Cell - metabolism Stem Cells - immunology Stem Cells - metabolism Stem Cells - pathology T-Lymphocytes - immunology T-Lymphocytes - metabolism T-Lymphocytes - pathology Tumor Cells, Cultured |
title | Kinetics of TCR Use in Response to Repeated Epitope-Specific Immunization |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A47%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kinetics%20of%20TCR%20Use%20in%20Response%20to%20Repeated%20Epitope-Specific%20Immunization&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Monsurro,%20Vladia&rft.date=2001-05-01&rft.volume=166&rft.issue=9&rft.spage=5817&rft.epage=5825&rft.pages=5817-5825&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.166.9.5817&rft_dat=%3Cproquest_cross%3E77073569%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c409t-d520c629bece3555584c8bbe554335cad07a6ac645618c361515591d9e0ec3773%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17842431&rft_id=info:pmid/11313426&rfr_iscdi=true |